| RS2101224520 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2101225889 |
PHGDH
|
Health Risk |
Likely pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2101248147 |
HMGCS2
|
Health Risk |
Likely pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS2101254797 |
HMGCS2
|
Health Risk |
Pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS2101262353 |
HMGCS2
|
Health Risk |
Pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS2101273359 |
HMGCS2
|
Health Risk |
Likely pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS2101282041 |
COL11A1
|
Health Risk |
Likely pathogenic |
COL11A1-related disorder, COL11A1-related disorder |
| RS2101283564 |
HMGCS2
|
Health Risk |
Pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS2101283660 |
HMGCS2
|
Health Risk |
Pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS2101305801 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS2101343665 |
HSD3B2
|
Health Risk |
Pathogenic |
— |
| RS2101349412 |
HSD3B2
|
Health Risk |
Pathogenic |
— |
| RS2101349426 |
HSD3B2
|
Health Risk |
Likely pathogenic |
Hypospadias 1, X-linked |
| RS2101349982 |
HSD3B2
|
Health Risk |
Pathogenic |
— |
| RS2101350040 |
HSD3B2
|
Health Risk |
Pathogenic |
— |
| RS2101350289 |
HSD3B2
|
Health Risk |
Pathogenic/Likely pathogenic |
3 beta-Hydroxysteroid dehydrogenase deficiency, 3 beta-Hydroxysteroid dehydrogenase deficiency |
| RS2101350432 |
HSD3B2
|
Health Risk |
Pathogenic |
— |
| RS2101350566 |
HSD3B2
|
Health Risk |
Pathogenic |
— |
| RS2101350819 |
HSD3B2
|
Health Risk |
Pathogenic |
— |
| RS2101370069 |
SLC35A3
|
Health Risk |
Pathogenic |
Autism spectrum disorder - epilepsy - arthrogryposis syndrome, Autism spectrum disorder - epilepsy - arthrogryposis syndrome |
| RS2101385559 |
C8B
|
Health Risk |
Pathogenic |
— |
| RS2101396301 |
KCNA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 32 |
| RS2101396443 |
KCNA2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 32 |
| RS2101396495 |
KCNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 32 |
| RS2101396713 |
KCNA2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 32 |
| RS2101397006 |
KCNA2
|
Health Risk |
Likely pathogenic |
— |
| RS2101398407 |
KCNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 32 |
| RS2101398595 |
KCNA2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 32 |
| RS2101398625 |
KCNA2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2101399429 |
KCNA2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 32 |
| RS2101399466 |
KCNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 32 |
| RS2101403658 |
KCNA2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 32 |
| RS2101406246 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 2, Stickler syndrome type 2 |
| RS2101406339 |
COL11A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome type 2, Stickler syndrome type 2 |
| RS2101408848 |
C8B
|
Health Risk |
Pathogenic |
— |
| RS2101422164 |
TBX15
|
Health Risk |
Pathogenic |
Pelviscapular dysplasia, Pelviscapular dysplasia |
| RS2101422204 |
TBX15
|
Health Risk |
Pathogenic |
Pelviscapular dysplasia, Pelviscapular dysplasia |
| RS2101429459 |
GPSM2
|
Health Risk |
Likely pathogenic |
Chudley-McCullough syndrome, Chudley-McCullough syndrome |
| RS2101440055 |
ECM1
|
Health Risk |
Pathogenic |
Lipid proteinosis, Lipid proteinosis |
| RS2101440353 |
ECM1
|
Health Risk |
Pathogenic |
Lipid proteinosis, Lipid proteinosis |
| RS2101487641 |
C8B
|
Health Risk |
Likely pathogenic |
— |
| RS2101501082 |
SLC35A3
|
Health Risk |
Pathogenic |
Autism spectrum disorder - epilepsy - arthrogryposis syndrome, Autism spectrum disorder - epilepsy - arthrogryposis syndrome |
| RS2101513438 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma/paraganglioma syndrome 4 |
| RS2101513489 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS2101513511 |
SDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS2101513669 |
SDHB
|
Health Risk |
Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Gastrointestinal stromal tumor |
| RS2101513801 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian cancer, Gastrointestinal stromal tumor |
| RS2101516291 |
SDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Gastrointestinal stromal tumor |
| RS2101516417 |
SDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Pheochromocytoma |
| RS2101516424 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma/paraganglioma syndrome 4 |
| RS2101516484 |
SDHB
|
Health Risk |
Likely pathogenic |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS2101516550 |
SDHB
|
Health Risk |
Likely pathogenic |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS2101521715 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS2101521720 |
SDHB
|
Health Risk |
Likely pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS2101521760 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS2101521812 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma/paraganglioma syndrome 4 |
| RS2101521836 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS2101521922 |
SDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS2101521941 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS2101522958 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS2101522991 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma/paraganglioma syndrome 4, Gastrointestinal stromal tumor |
| RS2101523059 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2101523108 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Pheochromocytoma |
| RS2101523248 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma, Pheochromocytoma/paraganglioma syndrome 4 |
| RS2101528079 |
GPSM2
|
Health Risk |
Likely pathogenic |
Chudley-McCullough syndrome, Chudley-McCullough syndrome |
| RS2101528919 |
SDHB
|
Health Risk |
Likely pathogenic |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS2101528951 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma, Pheochromocytoma/paraganglioma syndrome 4 |
| RS2101528972 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma, Pheochromocytoma/paraganglioma syndrome 4 |
| RS2101529108 |
SDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Paraganglioma, Gastrointestinal stromal tumor |
| RS2101529119 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS2101529138 |
SDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Pheochromocytoma |
| RS2101541309 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS2101541632 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma, Pheochromocytoma/paraganglioma syndrome 4 |
| RS2101542489 |
GPSM2
|
Health Risk |
Likely pathogenic |
Chudley-McCullough syndrome, Chudley-McCullough syndrome |
| RS2101551748 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma, Pheochromocytoma/paraganglioma syndrome 4 |
| RS2101551846 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma, Pheochromocytoma/paraganglioma syndrome 4 |
| RS2101551903 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS2101555526 |
DHCR24
|
Health Risk |
Conflicting classifications of pathogenicity |
Non-immune hydrops fetalis, Non-immune hydrops fetalis |
| RS2101557799 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS2101558812 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS2101563488 |
ADAR
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 6, Aicardi-Goutieres syndrome 6 |
| RS2101565765 |
ADAR
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 6, Aicardi-Goutieres syndrome 6 |
| RS2101568680 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS2101576292 |
ADAR
|
Health Risk |
Pathogenic |
Symmetrical dyschromatosis of extremities, Aicardi-Goutieres syndrome 6 |
| RS2101579172 |
ADAR
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 6, Aicardi-Goutieres syndrome 6 |
| RS2101582188 |
GFI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neutropenia, severe congenital |
| RS2101582643 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS2101584216 |
ADAMTSL4
|
Health Risk |
Pathogenic |
Ectopia lentis 2, isolated |
| RS2101584597 |
ADAMTSL4
|
Health Risk |
Pathogenic |
Ectopia lentis et pupillae, Ectopia lentis 2 |
| RS2101585615 |
TDRKH
|
Health Risk |
Pathogenic |
Azoospermia, Azoospermia |
| RS2101588892 |
ADAR
|
Health Risk |
Pathogenic |
Symmetrical dyschromatosis of extremities, Aicardi-Goutieres syndrome 6 |
| RS2101589045 |
ADAR
|
Health Risk |
Pathogenic |
Symmetrical dyschromatosis of extremities, Aicardi-Goutieres syndrome 6 |
| RS2101595036 |
COL11A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Stickler syndrome type 2, COL11A1-related disorder |
| RS2101602721 |
VPS13D
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome |
| RS2101615505 |
VPS13D
|
Health Risk |
Likely pathogenic |
Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome, Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome |
| RS2101615506 |
VPS13D
|
Health Risk |
Likely pathogenic |
— |
| RS2101619771 |
ADAR
|
Health Risk |
Pathogenic |
Symmetrical dyschromatosis of extremities, Aicardi-Goutieres syndrome 6 |
| RS2101621602 |
SLC16A1
|
Health Risk |
Likely pathogenic |
— |
| RS2101625861 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS2101627871 |
ADAMTSL4
|
Health Risk |
Likely pathogenic |
— |